The CBD industry has skyrocketed this past year with the overall market evaluation for 2019 reaching $5 billion, a 7x increase from 2018 according to the Brightfield Research Group. A term being googled more than Kanye West, a product being sold in major retailers nationwide, CBD has truly become a world-wide name. So just how did this industry reach such astronomical numbers in just a year? Well we’ve decided to help unravel that story through a comprehensive look at the industry this past year in the first-ever volume of our State of the Union: CBD Edition.
In order to accurately recap this year’s progress and takeaways, let’s first look back at 2014, when CBD was truly beginning to appear on everyone’s radar. Until the signing of the 2014 Farm Bill, hemp cultivation had been illegal in the U.S. for decades. Not only did the 2014 Farm Bill open the doors for hemp cultivation, it also established the guidelines to differentiate hemp from marijuana. To be legally classified as industrial hemp, the plant must contain .03 percent THC or less. While this was a huge win for industrial hemp advocates everywhere, it was still extremely difficult for businesses to begin product offerings.
Further handcuffed by the DEA’s opinion that industrial hemp remained on the list of federally banned substances, businesses had serious difficulties with establishing common business practices; access to traditional banks and financing, industrial extraction, merchant processing, Enterprise Resource Planning (ERP) software and relationships with mass retailers remained difficult if not completely unattainable.
Four long years later, this whisper of an industry evolved into a roar with the passing of the 2018 Farm Bill. While the 2014 Farm Bill brought industrial hemp cultivation back to American soil, it was the 2018 Farm Bill that explicitly removed hemp from the Controlled Substance Act (where it was classified under the umbrella as marijuana, LSD and heroin). This in turn removed hemp from the Drug Enforcement Agency’s (DEA) jurisdiction and their ability to interfere with congressional intent.2 It’s important to remember that CBD’s legal status is dependent not only on federal law but also on the state in which you reside. This Federal descheduling truly opened the door for the industry to begin to flourish.
“The 2018 Farm Bill was like the key that finally unlocked the handcuffs. Unshackled and free to roam, the industry was finally able to start adding color to the grey area surrounding it.” -Chase Terwilliger, CEO for Balanced Health Botanicals
The passing of this monumental bill created a snowball effect allowing other significant legislation to follow. For example, the House of Representatives recently made considerable progress on the to follow. For example, the House of Representatives recently made considerable progress on the Secure and Fair Enforcement (SAFE) Banking Act, which would provide banks and credit unions with additional clarity when servicing cannabis companies that want to open accounts for transactions such as paying for operating invoices. This is an important federal legislative advancement that will differentiate the CBD industry from the marijuana industry, enabling financial institutions previously unwilling to work with industrial hemp companies for fear of association with the marijuana business, to open their doors to the CBD industry.
With CBD business practices federally legal across the nation, even Federal agencies known for their strict policies like the Transportation Security Administration (TSA), were compelled to update their practices and policies. In an advisory statement for travelers, the TSA said, “products that contain hemp-derived CBD oil, or are FDA-approved, are generally legal and can fly.” They also updated their “What’s okay to bring?” website page to include more guidelines for acceptable forms of hemp derived-CBD oil.17
While the 2018 Farm Bill provided support for many components of the CBD industry, provisions in the law as related to the U.S. Food and Drug Administration’s (FDA) authority over all cannabis and cannabis-derived products continues to cause considerable confusion, particularly when determining whether a product is sourced from marijuana or hemp. The FDA maintains regulatory oversight of food, cosmetics, drugs and other products within its jurisdiction that have CBD, or the cannabis plant itself as an additive.
According to survey data compiled by the US- based Grocery Manufacturers Association (GMA), roughly three quarters (76%) of Americans may falsely believe that the FDA approves commercial CBD products. Consumer confusion grows as they presume that thousands of new products are marketed with FDA approval.12 Though the FDA is still working on developing its regulations, the agency’s primary concern centers on monitoring unsubstantiated medical claims and working in conjunction with the Federal Trade Commission to stop deceptive marketing practices.
The agency is committed to taking enforcement action against any companies making medical claims, selling its products as a supplement, or adding CBD to food. Hemp-derived products are not approved by the FDA as a medication or cure for any disorder (with the exception of the prescription Epidiolex, approved in 2018), and legality is left to the discretion of individual states.
With businesses now having access to banking and standard merchant processing through future bills such as the SAFE Banking Act, industrial extraction partners, software developers and traditional mass retailers took notice and decided to get involved.
When the federal government lifted restrictions on hemp cultivation, there was a significant increase in the number of industries incorporating industrial hemp and hemp-derived products into their business model. Farmers were converting their fields from traditional crops to industrial hemp; skincare companies were offering hemp-infused products to their customers and vape companies began opting for private label CBD. This all led to an increase in the number of retailers expanding their inventory to include CBD.
In 2014, when the industry was new, CBD sales generated $49 million. By the end of 2018, that number was $264 million. A 2016 article posted in the Hemp Business Journal estimated sales could top $2.1 billion by 2020 with predictions for the industry overall from the Brightfield Group seeing numbers as high as $22 billion by 2022.5
Just a few of the many retailers selling or planning to sell CBD products include:6
A huge concern for consumers purchasing their products from these retailers comes from the lack of education on regulation. To combat this, retailers currently selling CBD products are vetted to ensure that the FDA’s stringent guidelines are followed. Certifications like ISO-9001, which covers quality standards for manufacturing, and U.S. Hemp Authority™ Certification, which provides the high standards, best practices and self-regulation for consumers and law enforcement to ensure that hemp products are safe, must be obtained by the CBD companies. Many industry professionals believe with clear, consistent FDA regulatory guidelines, product quality will standardize and benefit the industry as a whole, but the process will take time. Currently, various government organizations are working on:
Previously, no traditional avenue of marketing or advertising was willing to work with the cannabis industry, but that all changed with the descheduling of CBD. The online traffic driven by those genuinely curious about CBD represented numbers advertisers could no longer ignore.
“Three years ago, there was essentially no one searching about CBD online, but now there are an estimated 6.4 million unique searches each month,” stated study co-author Dr. John Ayers, Vice Chief of Innovation in the Division of Infectious Disease and Global Public Health at the University of California, San Diego (UCSD), in a recent university release.15 To put this in perspective, cannabisMD, a non-advocacy educational platform, pulled data from user searches across the web and social media platforms to find that CBD is currently more searched than hugely popular searches like Kanye West, The NBA, Taylor Swift and more.16
Though large platforms like Facebook, Google, Amazon, Instagram and others, still have extremely strict policies on advertising CBD due to lack of FDA regulations, the spike of interest in CBD has caused breakthroughs on more traditional avenues like radio, print advertisements, billboards, out of home and some social media platforms.
To paint a picture of just how difficult marketing CBD currently is, first imagine a car salesman selling a vehicle with the potential to positively affect someone’s life in a major way. So, what’s the catch? Well you can’t directly speak to any of the car’s benefits and you surely can’t advertise on any conventional platforms. Sure, this shiny, new vehicle has leather seats, a sunroof, Bluetooth and a 5-star safety rating, but all you can say is that it has the potential to get you from point A to point B. Describing CBD has similar limitations. You may only advertise the potential benefits without making even a sliver of any medical claim about what CBD can provide you. This challenge, while extremely difficult to navigate, sparked a level of ingenuity among the companies within the space. Many companies spent the year building a stock of brand ambassadors who advocate their products for them, affiliates who are able to accurately review their products, and ad campaigns designated to emphasize credibility and quality, in order to set themselves apart from others via print, radio, online and the few available social media outlets.
These unconventional marketing avenues proved to truly make an impact as it’s nearly impossible to turn on the news without seeing a story about CBD. However, with over 3,000 companies currently in the space clawing for attention, a problem develops when these companies compete for a finite amount of advertising opportunities. Companies desperate for an edge over their competitors inevitably make false or misleading claims that taint the overall image of CBD products. Over the past few years, the FDA has issued warnings to numerous companies selling products that do not contain the levels of CBD they claimed to contain or making unlawful medical claims.7 As with any subject with too many unknowns surrounding it, the solution is the continued emphasis of transparency, research and the proliferation of educational materials.
Just how serious is this lack of education? According to research from the Grocery Manufacturers Association, four-in-ten Americans who have heard of CBD believe it’s another name for marijuana. More than half think it can get you high and 76 percent believe CBD is regulated at the federal level. 14
Sadly, at the moment there isn’t enough educational material on the topic to ensure unscrupulous manufacturers are not taking advantage of consumers. There are some key takeaways to help stop this spread of misinformation.
Firstly, unlike tetrahydrocannabinol (THC), a cannabinoid found primarily in marijuana, CBD (cannabidiol) does not produce any intoxicating or “high” effects. This means users can experience its benefits without disconcerting feelings of lethargy or dysphoria. Secondly, CBD interacts with the Endocannabinoid System (ECS), which is a collection of cell receptors and their corresponding molecules (agonists) in the human body. The ECS is responsible for regulating and maintaining many key functions of the human body. Lastly, hemp and marijuana are terms often used interchangeably to describe any cannabis plant or its derivatives. While they have many different chemical properties, according to the federal government, industrial hemp includes the plant Cannabis sativa L. and any part or derivative with a tetrahydrocannabinol (THC) concentration of no more than 0.3 percent on a dry weight basis.
“The discussion around CBD needs to evolve as more studies and research become available. Currently, companies should stick to what we actually know, which is how CBD is the most abundant of the 113-plus potentially beneficial cannabinoids found in the plant cannabis sativa L. By talking about these facts and directing the focus on consumer education for what to look for when purchasing CBD products, we can hopefully stop the spread of false information that will skew the public’s perception.” – Chris Van Dusen, CMO for Balanced Health Botanicals
On May 31, 2019, the FDA held its first public meeting as a forum for stakeholders to share their perspective on how CBD products could best be regulated. The goal of the meeting was to gather information and scientific data about the safety of hemp-derived products, product quality, manufacturing processes, product labeling and the marketing methods.
During this meeting, state regulators highlighted the need for FDA guidelines, consumer advocates expressed concern about the lack of scientific research, and industry leaders stressed the importance of adopting consistent terminology, uniform manufacturing practices and coherent quality standards.3 Although the FDA recognizes the growing support and public interest in CBD products, the organization is still in the process of gathering information, identifying risk factors, and investigating its regulatory options.
“The 2018 Farm Bill is proving to be the final nail in the coffin for the Federal Government’s long-standing moratorium on funding research designed to elucidate the full therapeutic potential of cannabinoids, or for that matter, any research that may have ultimately undermined the antiquated and hypocritical scheduling of cannabis as Schedule 1. What we are seeing right now is the ushering in of the golden-age of cannabinoid research. While we still have a long way to go to makeup for almost 80 years of lost time, one can’t help but feel optimistic as we move to an era where fact- and science-based data can drive rational decisions in areas such as medicine, policy, and personal liberty.” ~ John Harloe Ph.D., General Counsel for Balanced Health Botanicals
To support this mission, platforms like ValidCare, a Denver-based market intelligence and consumer research platform for the hemp industry, sprang into action by working with major CBD companies to gather data on consumer experiences with their products through its CBD+me™ app. Platforms like this are collecting as much information as possible in order to relay consumer data over to the FDA.13 Additionally, another Farm Bill requirement demands each state department of agriculture to submit a management plan to the USDA, outlining rules for hemp cultivation and processing in their respective jurisdictions.
In response, states like Colorado and the Colorado Department of Agriculture (CDA) partnered with leading state, local, and tribal agencies, as well as industry experts in cultivation, testing, research, processing, finance and economics to establish a statewide initiative known as the Colorado Hemp Advancement and Management Plan (CHAMP). These state funded programs will only add to the research need for the FDA to move forward with regulation.
Other government agencies are stepping in as well. The U.S. National Institute of Health (NIH) announced its approval of $3 million toward multiple studies on the effects of cannabis as a pain relief alternative. These grants, being funded by the NIH’s National Center for Complementary and Integrative Health (NCCIH), are designated to nine national studies on CBD. Now that funding has been freed up to be allocated to these studies and programs, it’s only a matter of time before the scientific evidence needed for regulation will become available.
FEDERALLY LEGAL: The 2018 Farm Bill officially classifies hemp as an agricultural commodity and removes it from the federal list of Controlled Substances. This impacts everything from direct shipping to payment processing and opens the market up to consumers across the country, removing all federal risk related to interstate commerce.
Federal acceptance of the hemp plant will lead to an influx of investment into all facets of the industry, from farming, to processing, to packaging and shipping. Likewise, we expect to see a proliferation of research studies into the hemp plant and its derivatives.
States rights will still prevail. Federally legal means states cannot prohibit shipping across their borders; State lawmakers can, however, adopt their own policy and stance relative to CBD sales and distribution in their state.
The 2018 Farm Bill defines hemp as all parts of the Cannabis sativa L plant, including “extracts” and “cannabinoids” with a THC concentration of <0.3%.
Hemp farmers will now be able to carry federally subsidized crop insurance and can fully participate in USDA programs for certification and competitive grants.
This bill brings us one step closer to destigmatizing the plant and industry as a whole, bringing greater consumer awareness of the medicinal benefits of cannabidiol and other hemp-derived cannabinoids. By de-scheduling hemp and removing it from the Controlled Substance Act, it opens up the possibility of public and private sponsored research programs.
Since leading Balanced Health Botanicals, the team has grown from four employees to 100+, increased product SKUs from one to over 800, and reported consolidated third-quarter revenue of $16.4 million, a 563% growth YoY. Chase’s goal is to continue the growth of the vertically integrated house of brands, becoming the largest supplier of hemp-derived CBD in the world.
Chris has spent the last 10 years in various executive level roles both in-house and at leading agencies, most recently at Parcon Media which he co-founded with the focus on Conversion Rate Optimization and high accountability media buying. Since joining BHB in early 2017 the company has seen torrid growth to the tune of $28 million in eCommerce sales in 2018 and $40 million overall.
A cum laude graduate of SMU Dedman School of Law, John also has a doctorate in Pharmacology & Toxicology from VCU Medical Center, where his research focused on cannabinoid and endocannabinoid research. Prior to joining BHB, John spent 8 years litigating and resolving mass tort claims against multi-national pharmaceutical and medical device companies.
Beanie Babies, pet rocks, and Rubik’s cubes were once insanely popular items. If you remember these products, you may also recall that interest diminished as the novelty wore off. When considering the increasing interest in CBD, many people, particularly those with a bit more life experience, wonder if the growing popularity suggests CBD is just another passing millennial fad.
If you’ve been curious about CBD products, it may be helpful to know that hemp-derived CBD is getting favorable reviews from people of all ages, including those 65 and older. Knowing the many reasons other seniors are using CBD could help you decide if these products could also be right for you.
Seniors are loving CBD (cannabidiol) for its ability to influence the receptors of their endocannabinoid systems (ECS), the largest regulatory system in your body. It’s the interaction between the messengers and receptors of this essential system that keep nearly every function in your body running the way it’s supposed to.
Under the effects of illness, stress, or injury, your body may need more ECS messengers than it can make. If that happens, communication can fail. CBD mimics the effects of the chemical messengers made in your body and interacts with the receptors of your endocannabinoid system. Just a few of the many functions regulated by your ECS include:
Your ability to fall asleep and sleep peacefully throughout the night is regulated by your circadian rhythms. Your endocannabinoid system regulates your circadian rhythms.
The activation of key ECS receptors has a direct impact on how hungry you feel, how your body processes nutrients, and how efficiently the foods you eat are converted to energy.
By regulating the release of serotonin, dopamine, norepinephrine, and more, your ECS plays a vital role in regulating fear, anxiety, depression, stress, and how you respond to their impact.1
Research shows that the cells of your immune system contain a large number of endocannabinoid receptors believed to be instrumental in balancing inflammatory responses and preventing immune system overactivity.
The areas of your brain crucial to memory and learning have a high concentration of endocannabinoid receptors. Researchers believe the abundance of ECS receptors suggests your endocannabinoid system directly influences your ability to adapt to and retrieve information.
Many seniors find the topic of CBD serving sizes a bit confusing. That’s understandable. Determining how much CBD you should take depends on several variables, including product type, CBD concentration, and how your body responds to CBD.
Everyone is different. A serving size that works for you might be too little or too much for someone else. To help determine your unique needs, consider the value of the following suggestion:
Many seniors trying CBD for the first time appreciate the option of a pre-measured product, the convenience of CBD capsules, softgels, or gummies. Most pre-measured CBD products contain an amount of CBD that works well for most people.
First time CBD users should start with a small serving size. A small amount of CBD can be anywhere between 2-30 mg. The choice is yours. If you don’t get the results you anticipated, increase by a small amount of CBD at your next serving.
It can take several days or several weeks for your body to start responding to CBD. That’s why it’s commonly recommended to increase your serving size slowly. Some seniors prefer increasing in small increments each serving; others choose to wait several days or a week to give their bodies time to adapt.
Although descriptions and reviews can tell you a lot about a product; you may not know what type of CBD works best for you until you try it. Many seniors find they prefer using different types of products depending on their needs. Some days you may find a topical preferable to a tincture; other days, you may find it better to use a combination of products.
Before making your first purchase, it’s essential to know how to differentiate between quality CBD products, and the poor quality or gimmicky products unlikely to give you the results you were hoping for. You can protect yourself from a disappointing purchase by remembering that genuine and gimmick products will have all or most of the following:
Quality CBD products specify the amount of CBD they contain in milligrams (mg). You should also be able to tell which part of the plant the oil was extracted from by looking on the manufacturer’s website or reading the product label. Genuine CBD is extracted from the stalks stems and flowers (aerial parts) of hemp plants. Reputable manufacturers will also provide access to their third-party test results and display certification by the US Hemp Roundtable, US Hemp Authority, National Hemp Association, or similar organizations.
Gimmicky products or products of questionable quality are often described in vague terms. Vendors use generic phrases like “high potency” or “extra strength” without specifying the CBD content. You may also find companies misrepresenting their products by marketing hemp seed oil as having similar value to CBD. That’s why it’s important to know that hemp seeds do not contain CBD. You may also find exaggerated health claims, no access to third-party tests, or gimmicky products like toothpicks or candles, products unlikely to provide any effect.
While browsing your options, you likely noticed there are numerous CBD products to choose from. The product you select should fit your needs and your lifestyle. Some of the many CBD products popular with senior citizens include:
CBD tinctures can be used in many ways. You can place the oil under your tongue and hold before swallowing or mix your CBDistillery™ tincture with your favorite beverage or recipe. CBD tinctures are an excellent option for those who are interested in finding the best value for their money.
For seniors with a sweet tooth, CBD gummies may be an ideal way to enjoy your CBD, a flavorful, fun option you will look forward to taking. CBDistillery™ 30mg Gummies are available in two types, one for use any time, and one specially formulated to use at night.
CBD capsules are most often preferred by seniors looking for a convenient way to take CBD. All CBDistillery™ Capsules contain a pre-measured serving of CBD in a convenient form that’s easy to swallow and easy to add to your current pill or vitamin regimen.
Topicals are ideal for seniors who want targeted benefits in a specific area of their body. CBDistillery™ Topicals can be used on their own, or to enhance the effects of ingestible CBD products. CBDistillery™ has two topical products. One is formulated with arnica, lavender, and other botanicals chosen for their potential to help soothe joints and muscles; the other is blended with skin-soothing ingredients including olive oil, apricot oil, and frankincense.
Although CBD is considered a safe, natural product with little risk of side effects, CBD use is not recommended for everyone. If you have a medical condition or take medication, it’s important to discuss your interest in CBD with your doctor before ordering.
Seniors looking for high-quality products at reasonable prices place their trust in CBDistillery™ products. CBDistillery™ CBD products are crafted from non-GMO industrial hemp grown using natural farming methods. Our hemp oil is CO2 extracted and third-party tested so you can verify the purity and potency of our product by viewing the test results on our website or scanning the QR code on your product label.
NHL players are some of the toughest sports professionals to be found anywhere. Not only do players train hard to perfect their skills on the ice, players are routinely punched, kicked, shinned, and thrown into panes of glass during competition.
Since post-workout recovery is vital to player performance and team success, many NHL players are adding CBD to their daily routine. Understanding some of the many ways CBD helps keep the puck moving for hockey players might help you determine if hemp-derived products could be beneficial for you.
NHL players love using CBD because this safe, natural product is shown to support numerous functions by interacting with the receptors of the endocannabinoid system (ECS), the largest regulatory system in your body. CBD is shown to mimic the effects of the messengers made in the body and interact with ECS receptors. Just a few of the many processes regulated by ECS function include:
Professional athletes across multiple sports are loving what CBD provides. Since their careers depend on their ability to rest and recover, numerous professional athletes are using CBD to support essential functions throughout their bodies, including the following CBDistillery™ Brand Ambassadors:
Mixed martial arts is described as one of the most dynamic and challenging full-contact sports. Michelle Waterson relies on a combination of throws, holds, kicks, punches, and takedowns to achieve dominance over her competition. This MMA fighter uses CBD to help calm her mind and enhance recovery.
Mixed martial artist Anthony Pettis was the final WEC Lightweight Champion before the organization merged with the UFC. Today, Anthony Pettis is a competitor in the Lightweight division of the UFC. To take full advantage of CBD’s potential influence on training and recovery, this Brand Ambassador relies on a variety of CBD products.
Peregrine Performance Racing is an elite track and criterium cycling team based in Southern California. Team members maintain fitness and stamina with high-intensity workouts and weight training to keep their bodies in top form. Fitness recovery is considered a contributing factor in team success.
Albee Layer is a boundary-pushing surfer credited for flopping the script on the sport while making his name known throughout the surf community worldwide. Hailing from Maui’s North Shore, Albee is known for his go-for-broke, raw, progressive style. Albee Layer is also one of numerous elite athletes using hemp-derived CBD products.
Yes. The NHL is one of the most progressive of all professional sports leagues in terms of cannabis use. The organization has no policies prohibiting the use of CBD products. Although the NHL does routinely test for marijuana, players are not penalized if they test positive. If a significant amount of THC (indicating heavy use) were to be detected, players are usually sent to a behavioral health program rather than being suspended or fined.2 Currently, the NFL, NBA, and MLB have a much more punitive approach to cannabis use.
Many NHL players are quite enthusiastic about their experiences using CBD products. It may be interesting to note that the head of the NHL Alumni Association, Glenn Healy, recently announced a CBD study to examine the therapeutic potential of the cannabinoid for former athletes.3 Just a few of the many products NHL players are using to keep the puck moving include:
The product most often called CBD oil is a blend of hemp extract and a carrier oil, a tincture. CBDistillery™ Full-Spectrum 1000mg CBD Tincture is a medium strength product that works well for many players. CBD tinctures are easy to use; simply place the oil under your tongue and hold a few seconds before swallowing.
CBD products are ideal for rubbing down muscles after a grueling game or strenuous workout. CBDistillery™ CBDol Topical CBD Salve is specially formulated with eucalyptus, arnica, lavender, and other natural botanicals.
Vaping is an easy CBD option for players on the go and the fastest method of CBD delivery. CBDistillery™ 200mg Disposable Vape Pens are ready to use right out of the box and available in a wide variety of flavors. Our vape pens and cartridges are powered with CCELL technology, a state-of-the-art wickless atomizer system.
Hockey can be a rough sport. A growing number of NHL players are using hemp-derived CBD for its potential to support the function of their endocannabinoid system and enhance their recovery efforts.
To learn more about your endocannabinoid system, visit CBDistillery™ to download The Ultimate CBD User Guide. While your there, you may want to take a moment to view our quality selection of CBD topicals, tinctures, capsules, and CBD vape products. All CBDistillery™ products are third-party tested to ensure the purity and potency of every product we offer.
BHB implements various protocols and procedures to ensure their customers have full trust in the safety and quality of their products. Over the course of a year, BHB partnered with academic experts to develop GRAS dossiers that were then submitted to a third-party panel of toxicologists to determine the safety of their CBD full-spectrum extract and CBD isolate, and thus awarding the status of self-affirmed GRAS.
“As the leaders of the #CBDMOVEMENT™, consumer safety is our first and foremost priority and the self-affirmed GRAS certification is a huge step for both Balanced Health Botanicals and the growing CBD industry,” said CEO Chase Terwilliger. “We are dedicated to providing safe and high-quality products– our customers deserve nothing less. The self-affirmed GRAS status adds upon our list of industry leading safety protocols. We encourage all CBD companies to take the right steps for the consumers and go through the GRAS process for their extracts,” said CEO Chase Terwilliger.
Balanced Health Botanicals™ owns and operates some of the largest brands in the hemp-derived CBD industry, including CBDistillery™, the flagship brand of BHB, CBDistilleryRx, retail exclusive line of broad-spectrum hemp-derived CBD products to help improve overall health and wellness and BOTA™, luxurious plant-powered, hemp-derived CBD skincare and supplements.
For more information on Balanced Health Botanicals, their products and their mission, please visit: https://www.balancedhealthbotanicals.com.
About Balanced Health Botanicals:
Balanced Health Botanicals™ (BHB) is a vertically integrated family of hemp-derived CBD brands that includes CBDistillery™, BOTA™, and CBDistilleryRx™. Flagship brand CBDistillery™ was founded in Denver in 2016 to pursue a rapidly growing and predominantly untapped market. It has since evolved into one of the largest and most cost-effective brands in the CBD market, sold in retailers nationwide. CBDistilleryRx™ is a retail-exclusive line of broad-spectrum hemp-derived CBD products that combines the power of CBD with proven, effective ingredients to help improve overall health and wellness. The all-new BOTA™ is a line of premium plant-powered skincare and supplements that combines powerful natural botanicals with hemp-derived CBD. BHB’s mission is to provide the highest quality, U.S. grown, hemp-derived CBD products at fair prices and to be the premier CBD education resource. BHB has made significant investments in its infrastructure, supply chain capabilities and product portfolio to solidify itself as the leader of the #CBDMOVEMENT™.
Campaign Provides a Call-to-Action for Industry Players to Step Up with Real Results, or Get Out
Denver, CO (July 15, 2019) Balanced Health Botanicals™ (BHB™), parent company to the fast-growing CBDistillery™ brand, today unveiled their Gimmick-Free CBD campaign calling out companies that are taking advantage of the emerging and unregulated CBD industry. Consumers are being targeted with everything from toothpicks to candles, as CBD is being incorporated in products to grab their attention and drive sales, nullifying the importance of supplementing high-quality CBD.
The campaign also intends to legitimize brands – like CBDistillery – that provide real products, with real results, and help consumers understand what CBD products they can trust to provide wellness for both mind and body.
“From legislators to industry players and consumers, there is already confusion surrounding this compound and the future of the industry. This wild west of gimmicky products on the market are only hindering positive industry progress,” says CMO Chris Van Dusen. “Our company was founded with a mission of providing real products we believe in without all the gimmicks and it is time for someone to step up and challenge the current trend of using CBD as a buzzword simply to help sell products. We want to empower our consumers with the knowledge to purchase products they not only understand how and why to use, but that they can trust.”
With over 3,000 companies currently occupying the space and even more being created, CBDistillery’s Gimmick-Free campaign was born out of a necessity to highlight the misuse of CBD that has spread throughout the industry. This campaign is providing a call-to-action for consumers to pay attention and look beyond the marketing ploys before making purchasing decisions. With the industry under a fine microscope, it is also a call-to-action for industry leaders to guarantee their products are third-party tested and trustworthy.
CBDistillery’s campaign will launch July 15th with a prominent 7-billboard display in Times Square featuring a number of gimmicky CBD products – from toilet paper to condoms – compared to their own gimmick-free products. To amplify the campaign, the Times Square launch will be followed by an omnichannel marketing approach across social media, radio, email campaigns, direct mail and strategically placed advertisements.
As leaders of the #CBDMovement, CBDistillery is committed to providing the highest quality, U.S.-grown hemp-derived CBD products, at the most affordable prices and to being the premier CBD education resource.
For more information on BHB’s CBDistillery Gimmick-Free CBD campaign, please visit: GimmickFreeCBD.co.
About Balanced Health Botanicals:
Balanced Health Botanicals™ (BHB) is a vertically integrated family of hemp-derived CBD brands. The flagship brand CBDistillery™ was founded in Denver, CO in 2015 to pursue a rapidly growing and predominantly untapped market. It has since evolved into one of the largest and most cost-effective brands in the CBD market, sold in retailers nationwide. BHB brands CBDistilleryRx™ and BOTA™ were created to further satisfy the needs of consumers in offering pharmacist-recommended CBD and premium skincare products. BHB’s mission is to provide the highest quality, U.S.-grown, hemp-derived CBD products at fair prices and to be the premier CBD education resource. BHB has made significant investments in its infrastructure, supply chain capabilities and product portfolio to solidify itself as the leader of the #CBDMOVEMENT™.